AstraZeneca Pulls Exanta After Liver Injury Case
LONDON, Feb 14 (Reuters) - AstraZeneca Plc has decided to withdraw its Exanta drug worldwide following a case of serious liver injury, throwing in the towel on the anticoagulant which was rejected by U.S. regulators in 2004.